MRC — Mercator Medical SA Share Price
Last trade - 00:00- PLN543.20m
- PLN425.53m
- PLN574.18m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.57 | ||
| Price to Tang. Book | 0.59 | ||
| Price to Free Cashflow | 262.04 | ||
| Price to Sales | 0.88 | ||
| EV to EBITDA | 5.04 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 5.48% | ||
| Return on Equity | 7.22% | ||
| Operating Margin | 8.58% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | PLNm | 1,727.35 | 542.51 | 469.06 | 542.49 | 574.18 | n/a | n/a | -20.73% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -48.57 | n/a | n/a | n/a | -31.31 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Mercator Medical SA is a Poland-based company engaged in medical supplies industry. The Company manufactures medical gloves and distributes disposable medical materials. It produces medical, latex, synthetic, surgical, diagnostic sterile, examination and protective and household gloves. Its dressing products line includes gauze dressing products, non-woven fabric dressing, medical adhesive tapes, surgical dressing, among others. In addition, the Company provides drapes such as bed sheets, sets, as well as apparel, including caps, masks, gowns, among others. It operates through subsidiaries: Mercator Medical Kft, Mercator Medical srl, Merkator Medikal TOB, Mercator Medical (Thailand) Ltd and VIVOFT LLP.
Directors
- Urszula Zyznowska CSU (48)
- Wieslaw Zyznowski CMG (54)
- Piotr Solorz VSU (48)
- Monika Zyznowska VMG (33)
- Dariusz Krezymon MGB
- Michal Romanski MGB
- Jaroslaw Karasinski IND (53)
- Marian Slowiaczek IND (69)
- Gabriela Stolarczyk-Zadecka IND
- Witold Kruszewski SUB (43)
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- August 31st, 2001
- Public Since
- November 21st, 2013
- No. of Employees
- 833
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Warsaw Stock Exchange
- Shares in Issue
- 9,144,813
- Address
- Heleny Modrzejewskiej 30, KRAKOW, 31-327
- Web
- https://pl.mercatormedical.eu/
- Phone
- +48 126655400
- Auditors
- PKF Polska
Latest News for MRC
Upcoming Events for MRC
Similar to MRC
Advanced Medical Equipment SA
Warsaw Stock Exchange
Airway Medix SA
Warsaw Stock Exchange
BioMaxima SA
Warsaw Stock Exchange
CM International SA
Warsaw Stock Exchange
Massmedica SA
Warsaw Stock Exchange
FAQ
As of Today at 04:03 UTC, shares in Mercator Medical SA are trading at PLN59.40. This share price information is delayed by 15 minutes.
Shares in Mercator Medical SA last closed at PLN59.40 and the price had moved by +41.94% over the past 365 days. In terms of relative price strength the Mercator Medical SA share price has outperformed the FTSE Global All Cap Index by +24.34% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Mercator Medical SA dividend yield is 2.76% based on the trailing twelve month period.
Last year, Mercator Medical SA paid a total dividend of PLN1.64, and it currently has a trailing dividend yield of 2.76%. We do not have any data on when Mercator Medical SA is to next pay dividends.
We do not have data on when Mercator Medical SA is to next pay dividends. The historic dividend yield on Mercator Medical SA shares is currently 2.76%.
To buy shares in Mercator Medical SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of PLN59.40, shares in Mercator Medical SA had a market capitalisation of PLN543.20m.
Here are the trading details for Mercator Medical SA:
- Country of listing: Poland
- Exchange: WSE
- Ticker Symbol: MRC
Based on an overall assessment of its quality, value and momentum Mercator Medical SA is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Mercator Medical SA is PLN23.10. That is 61.11% below the last closing price of PLN59.40.
Analysts covering Mercator Medical SA currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Mercator Medical SA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +11.38%.
As of the last closing price of PLN59.40, shares in Mercator Medical SA were trading +17.41% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Mercator Medical SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at PLN59.40.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Mercator Medical SA's management team is headed by:
- Urszula Zyznowska - CSU
- Wieslaw Zyznowski - CMG
- Piotr Solorz - VSU
- Monika Zyznowska - VMG
- Dariusz Krezymon - MGB
- Michal Romanski - MGB
- Jaroslaw Karasinski - IND
- Marian Slowiaczek - IND
- Gabriela Stolarczyk-Zadecka - IND
- Witold Kruszewski - SUB